Read More 1 minute read Funding News News Therapeutics Halda Therapeutics Secures $126M to Advance Novel RIPTAC Cancer Therapies Key Highlights Halda Therapeutics raises $126M in Series B extension, total $202M funding to date. Proceeds will advance… byChris-Anne RoqueAugust 15, 2024